Cargando…
A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and...
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209156/ https://www.ncbi.nlm.nih.gov/pubmed/34135391 http://dx.doi.org/10.1038/s41598-021-92070-w |
| _version_ | 1783709067873615872 |
|---|---|
| author | Carter, Nikki Clausen, Maryam Halpin, Rebecca A. Blackmore, Colin Cai, Kang Delpuech, Oona Kohlmann, Alexander Magnusson, Otto March, Ruth O’Neill, Daniel Prakash, Kasthuri Sherwood, James Sundin, Tabetha Swift, Jason Tarakameh, Azar Wijdicks, Marilou Wise, Daniel Fidock, Mark |
| author_facet | Carter, Nikki Clausen, Maryam Halpin, Rebecca A. Blackmore, Colin Cai, Kang Delpuech, Oona Kohlmann, Alexander Magnusson, Otto March, Ruth O’Neill, Daniel Prakash, Kasthuri Sherwood, James Sundin, Tabetha Swift, Jason Tarakameh, Azar Wijdicks, Marilou Wise, Daniel Fidock, Mark |
| author_sort | Carter, Nikki |
| collection | PubMed |
| description | Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type. |
| format | Online Article Text |
| id | pubmed-8209156 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82091562021-06-17 A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce Carter, Nikki Clausen, Maryam Halpin, Rebecca A. Blackmore, Colin Cai, Kang Delpuech, Oona Kohlmann, Alexander Magnusson, Otto March, Ruth O’Neill, Daniel Prakash, Kasthuri Sherwood, James Sundin, Tabetha Swift, Jason Tarakameh, Azar Wijdicks, Marilou Wise, Daniel Fidock, Mark Sci Rep Article Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type. Nature Publishing Group UK 2021-06-16 /pmc/articles/PMC8209156/ /pubmed/34135391 http://dx.doi.org/10.1038/s41598-021-92070-w Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Article Carter, Nikki Clausen, Maryam Halpin, Rebecca A. Blackmore, Colin Cai, Kang Delpuech, Oona Kohlmann, Alexander Magnusson, Otto March, Ruth O’Neill, Daniel Prakash, Kasthuri Sherwood, James Sundin, Tabetha Swift, Jason Tarakameh, Azar Wijdicks, Marilou Wise, Daniel Fidock, Mark A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title | A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title_full | A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title_fullStr | A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title_full_unstemmed | A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title_short | A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce |
| title_sort | novel automated sars-cov-2 saliva pcr test protects a global asymptomatic workforce |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209156/ https://www.ncbi.nlm.nih.gov/pubmed/34135391 http://dx.doi.org/10.1038/s41598-021-92070-w |
| work_keys_str_mv | AT carternikki anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT clausenmaryam anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT halpinrebeccaa anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT blackmorecolin anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT caikang anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT delpuechoona anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kohlmannalexander anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT magnussonotto anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT marchruth anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT oneilldaniel anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT prakashkasthuri anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT sherwoodjames anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT sundintabetha anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT swiftjason anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT tarakamehazar anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT wijdicksmarilou anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT wisedaniel anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT fidockmark anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT carternikki novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT clausenmaryam novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT halpinrebeccaa novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT blackmorecolin novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT caikang novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT delpuechoona novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kohlmannalexander novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT magnussonotto novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT marchruth novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT oneilldaniel novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT prakashkasthuri novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT sherwoodjames novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT sundintabetha novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT swiftjason novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT tarakamehazar novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT wijdicksmarilou novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT wisedaniel novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT fidockmark novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce |